Related Experiment Video

Updated: Aug 24, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

"Positive" Tc-99m red blood cell scintigraphy in a patient with hepatic lymphoma

Nir Hod1, Mehrzad Cohen Pour, Yoav Juven

  • 1Department of Nuclear Medicine, Assaf Harofeh Medical Center, Zerifin and Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Clinical Nuclear Medicine
|April 21, 2004
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT
11:34

Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT

Published on: April 29, 2017

Related Experiment Videos

Last Updated: Aug 24, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT
11:34

Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT

Published on: April 29, 2017

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Articles linked to this work by shared authors, journal, and citation graph.

Metastatic Prostate Carcinoma to the Ankle Seen on Bone Scintigraphy and Extended Field-of-View PSMA PET/CT.

Clinical nuclear medicine·2024

Burned-Out Testicular Carcinoma Presenting as Inferior Vena Cava Tumor Thrombus With Pulmonary Tumor Embolism on FDG PET/CT: A Case Report.

Clinical nuclear medicine·2024

Uncommon Detection of Leiomyoma in the Penile Corpus Spongiosum Using FDG PET/CT: A Case Report.

Clinical nuclear medicine·2024

Incidental Detection of Dual Spinal Meningiomas on 68 Ga-DOTATATE PET/CT Masquerading as Metastatic Disease in a Patient With Pulmonary Carcinoid Tumor.

Clinical nuclear medicine·2023

The Usefulness of Short-Interval Sequential FDG PET/CT Studies in Defining the Benignity of Hypermetabolic Lipomatous Tumor.

Clinical nuclear medicine·2023

Progressive Transformation of Germinal Centers Simulating Malignant Axillary Lymphadenopathy in a Breast Cancer Patient on FDG PET/CT.

Clinical nuclear medicine·2023

One Tracer, Whole Syndrome: CAIX-Targeted PET Unmasks the Multisystem Tumor Landscape of Von Hippel-Lindau Disease.

Clinical nuclear medicine·2026

18F-FET PET Pitfall in Pituitary Imaging: False-positive Uptake Due to Neurosarcoidosis.

Clinical nuclear medicine·2026

18F-FDG PET/CT Manifestations of a Gastrointestinal Stromal Tumor Presenting With Predominant Hepatic and Peritoneal Metastases.

Clinical nuclear medicine·2026

18F-THK5351 PET Findings Indicative of Reactive Astrogliosis in Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy.

Clinical nuclear medicine·2026

Reversing the Reverse: Nitrate-Enhanced Tc-99m MIBI MPS Unmasking Microvascular Dysfunction in Takayasu Arteritis.

Clinical nuclear medicine·2026

The "Scintigraphic Flip": A Visual Warning Sign of Impending Hematologic Toxicity.

Clinical nuclear medicine·2026

HIV and Antiretroviral Therapy Influence Tumor Microenvironment Architecture, Subclonal Evolution, and Immune Evasion Strategies in Diffuse Large B-Cell Lymphoma.

Cancer research communications·2026

Spontaneous Triceps Haematoma Presenting With Ulnar Neuropathy: A Report of a Rare Case.

Cureus·2026

Integrative Multiomics Profiling Reveals Immune Determinants of Response to Disitamab Vedotin Plus Penpulimab in HER2-Low Breast Cancer.

MedComm·2026

Tumour-agnostic immunotherapy: aligning biological rationale, biomarker precision, and real-world implementation.

EClinicalMedicine·2026

Gastric cancer tertiary lymphoid structures in the muscularis propria are associated with therapy resistance and promote immunosuppression.

Nature communications·2026

Jugulotympanic paraganglioma, preoperative embolization, and transmastoid retrolabyrinthine approach: Two-dimensional operative video.

Surgical neurology international·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us